1. Home
  2. DRCT vs GDTC Comparison

DRCT vs GDTC Comparison

Compare DRCT & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Direct Digital Holdings Inc.

DRCT

Direct Digital Holdings Inc.

HOLD

Current Price

$0.07

Market Cap

8.9M

Sector

Technology

ML Signal

HOLD

Logo CytoMed Therapeutics Limited

GDTC

CytoMed Therapeutics Limited

HOLD

Current Price

$1.55

Market Cap

24.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRCT
GDTC
Founded
2018
2018
Country
United States
Singapore
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.9M
24.8M
IPO Year
2022
2023

Fundamental Metrics

Financial Performance
Metric
DRCT
GDTC
Price
$0.07
$1.55
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
30.0M
37.9K
Earning Date
11-06-2025
04-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$35,369,000.00
$573,193.00
Revenue This Year
N/A
$5.37
Revenue Next Year
$25.40
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
63.03
52 Week Low
$0.06
$1.38
52 Week High
$6.59
$4.05

Technical Indicators

Market Signals
Indicator
DRCT
GDTC
Relative Strength Index (RSI) 24.71 30.94
Support Level $0.06 $1.53
Resistance Level $0.08 $1.66
Average True Range (ATR) 0.01 0.14
MACD 0.00 -0.02
Stochastic Oscillator 11.01 4.05

Price Performance

Historical Comparison
DRCT
GDTC

About DRCT Direct Digital Holdings Inc.

Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Share on Social Networks: